Skin wounds and sores, such as diabetic foot sores and pressure wounds, present a growing healthcare problem. These injuries are exacerbated by co-morbidities affecting circulation and healing responses, as well as by limitations to an individual’s mobility. As such, they are particularly prevalent in hospital and long-term care settings. Combatting these wounds involves both managing the exposed tissue and treating any infection using topical and/or systemic antibiotics. Characterizing the bacterial composition of the skin microbiome, as well as infected wounds, is paramount for effective treatment and to prevent further antibiotic resistance.
![[Guide] 7 Strategies to Boost Laboratory Collaboration](https://d3bkbkx82g74b8.cloudfront.net/eyJidWNrZXQiOiJsYWJyb290cy1pbWFnZXMiLCJrZXkiOiJjb250ZW50X2FydGljbGVfcHJvZmlsZV9pbWFnZV83YzBjZWIwM2Y5YzI4MmFlYzBhZDZhMTcyNTQ1ZGU3YmE4Y2MzMDYyXzUxNDkuanBnIiwiZWRpdHMiOnsidG9Gb3JtYXQiOiJqcGciLCJyZXNpemUiOnsid2lkdGgiOjcwMCwiaGVpZ2h0IjozNTAsImZpdCI6ImNvdmVyIiwicG9zaXRpb24iOiJjZW50ZXIiLCJiYWNrZ3JvdW5kIjoiI2ZmZiJ9LCJmbGF0dGVuIjp7ImJhY2tncm91bmQiOiIjZmZmIn19fQ==)
Space & Astronomy
New Study Provides Origins of Asteroid (52246) Donaldjohanson
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.
